Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL.
Cancers (Basel). 2023 Sep 30;15(19):4823. doi: 10.3390/cancers15194823.
Cancers (Basel). 2023.
PMID: 37835517
Free PMC article.
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Maio M, Lewis K, Demidov L, Mandalà M, Bondarenko I, Ascierto PA, Herbert C, Mackiewicz A, Rutkowski P, Guminski A, Goodman GR, Simmons B, Ye C, Yan Y, Schadendorf D; BRIM8 Investigators.
Maio M, et al.
Lancet Oncol. 2018 Apr;19(4):510-520. doi: 10.1016/S1470-2045(18)30106-2. Epub 2018 Feb 21.
Lancet Oncol. 2018.
PMID: 29477665
Clinical Trial.
Item in Clipboard
Small-cell carcinoma of the penile urethra: a case report and a short review of the literature.
Altintas S, Blockx N, Huizing MT, Van den Brande J, Hoekx L, Bogers JP, Van Marck E, Vermorken JB.
Altintas S, et al. Among authors: blockx n.
Ann Oncol. 2007 Apr;18(4):801-4. doi: 10.1093/annonc/mdl457. Epub 2006 Dec 20.
Ann Oncol. 2007.
PMID: 17182974
Free article.
No abstract available.
Item in Clipboard
Cite
Cite